Skip to main content
SpringerLink
Log in

Modification of adriamycin toxicity in rats fed a high fat diet

  • Models in Toxicology
  • Published:
Agents and Actions Aims and scope Submit manuscript

Abstract

Rats fed a diet containing a high percentage of butter, cholesterol, cholic acid and propyl thiouracil (HFD) showed weight loss and developed hyperlipidemia, marked fatty in filtration of the liver, moderate elevation of SGPT, degenerative changes of the heart muscle, bradycardia, alterations of the QRS complex in the electrocardiogram, and initial hemoconcentration followed by moderate anemia. Treatment with adriamycin (18×1 mg/kg i.p.) resulted in significant augmentation of the cardiotoxic effects of this drug demonstrated by electrocardiographic measurements and myocardial histopathology. Adriamycin-induced atrophy of the lymphatic tissue was seen only in rats fed HFD and not in animals receiving ground chow. Adriamycin levels in the heart after single i.p. injection were higher in rats receiving HFD. This effect was present already after 10 days on HFD. At this time histopathological liver changes were present and SGPT was elevated. It is concluded that the increase in adriamycin toxicity is, at least in part, due to diminished excretion by the liver. These experimental findings are in accordance with clinical observations which have identified liver disease as one of the important risk factors for the development of adriamycin cardiomyopathy.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. G. Zbinden,Experimental and Clinical Aspects of Drug Toxicity, Advances Pharmac.2, 1–112 (1963).

    Google Scholar 

  2. S. Renaud andC. Allard,Thrombosis in Connection with Serum Lipid Changes in the Rat, Circ. Res.11, 388–399 (1962).

    PubMed  Google Scholar 

  3. G. Zbinden andE. Brändle,Toxicologic Screening of Daunorbicin (NSC-82151), Adriamycin (NSC-123 127), and Their Derivatives in Rats, Cancer Chemother. Rep., Part 1,59, 707–715 (1975).

    Google Scholar 

  4. B. Romeis,Mikroskopische Technik, 16th edition (R. Oldenbourg Verlag, München-Wien, 1968, pp. 371–372.

    Google Scholar 

  5. N.R. Bachur andJ.C. Cradock,Daunomycin Metabolism in Rat Tissue Slices, J. Pharmacol. exp. Ther.175, 331–337 (1970).

    PubMed  Google Scholar 

  6. N.R. Bachur, A.L. Moore, J.G. Bernstein andA. Liu,Tissue Distribution and Disposition of Daunomycin (NSC-82151) in Mice: Fluorimetric and Isotopic Methods, Cancer Chemother. Rep., Part 1,54, 89–94 (1970).

    Google Scholar 

  7. J.C. Cradock, M.J. Egorin andN.R. Bachur,Daunorubicin Biliary Excretion and Metabolism in the Rat, Arch int. Pharmacodyn.202, 48–61 (1973).

    PubMed  Google Scholar 

  8. G.R. Bartlett,Phosphorus Assay in Column Chromatography, J. Biol. Chem.234, 466–571 (1959).

    PubMed  Google Scholar 

  9. J. Grauwiler,Herz und Kreislauf der Säugetiere (Birkhäuser Verlag, Basel and Stuttgart, 1965).

    Google Scholar 

  10. A. Di Marco, M. Gaetani andB. Scarpinato,Adriamycin: A New Antibiotic with Antitumor Activity, Cancer Chemother. Rep., Part 1,53, 33–37 (1969).

    Google Scholar 

  11. G. Bonnadonna, S. Monfardini M. De Lena andF. Fossati-Bellani,Clinical Evaluation of Adriamycin, A New Antitumor Antibiotic, Br. Med. J.3, 503–506 (1969).

    PubMed  Google Scholar 

  12. R.H. Blum andS.K. Carter,Adriamycin, A New Anticancer Drug with Significant Clinical Activity, Ann. Intern. Med.80, 249–259 (1974).

    PubMed  Google Scholar 

  13. R.S. Benjamin,A Practical Approach to Adriamycin (NSC-123 127) Toxicology, Cancer Chemother. Rep., Part 3,6, 191–194 (1975).

    Google Scholar 

  14. E.A. Lefrak, J. Pitha, S. Rosenheim, R.M., O'Bryan, M.A. Burgess andJ.A. Gottlieb,Adriamycin (NSC-123 127) Cardiomyopathy, Cancer Chemother. Rep., Part 3,6, 203–208 (1975).

    Google Scholar 

  15. G. Bonadonna, G. Beretta, G. Tancini, C. Brambilla, E. Bajetta, G.M. De Palo, M. De Lena, F. Fossati-Bellani, M. Gasparini, P. Valagussa andU. Veronesi,Adriamycin (NSC-123 127) Studies at the Istituto Nazionale Tumori, Milan, Cancer Chemother. Rep., Part 3,6, 231–245 (1975).

    Google Scholar 

  16. R.A. Minow, R.S. Benjamin andJ.A. Gottlieb,Adriamycin (NSC-123 127) Cardiomyopathy. An Overview with Determination of Risk Factors, Cancer Chemother. Rep., Part 3,6, 195–201 (1975).

    Google Scholar 

  17. E.P. Cortes, G. Lutman, J. Wanka, J.J. Wang, J. Pickren, J. Wallace andJ.F. Holland,Adriamycin (NSC-123 127) Cardiotoxicity: A Clinicopathologic Correlation, Cancer Chemother. Rep., Part 3,6, 215–225 (1975).

    Google Scholar 

  18. A.C. Gilladoga, C. Manuel, C.T.C. Tan, N. Wollner, S.S. Sternberg, andM.L. Murphy,The Cardiotoxicity of Adriamycin and Daunomycin in Children, Cancer37, 1070–1078 (1976).

    PubMed  Google Scholar 

  19. J.P. Kushner, V.L. Hansen andS.P. Hammar,Cardiomyopathy after Widely Separated, Courses of Adriamycin Exacerbated by Actionmycin-D and Mithramycin, Cancer36, 1577–1584 (1975).

    PubMed  Google Scholar 

  20. R.S. Benjamin, P.H. Wiernik andN.R. Bachur,Adriamycin Chemotherapy.—Efficacy, Safety, and Pharmacologic Basis of an Intermittent Single High-Dosage Schedule, Cancer33, 19–27 (1974).

    PubMed  Google Scholar 

  21. R.S. Benjamin,Clinical Pharmacology of Adriamycin (NSC-123 127) Cancer Chemother. Rep., Part 3,6, 183–185 (1975).

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Institute of Toxicology, Federal Institute of Technology and University of Zurich, Schorenstrasse 16, 8603, Schwerzenbach, Switzerland

    G. Zbinden, E. Brändle & M. Pfister

Authors
  1. G. Zbinden
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. E. Brändle
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. M. Pfister
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Zbinden, G., Brändle, E. & Pfister, M. Modification of adriamycin toxicity in rats fed a high fat diet. Agents and Actions 7, 163–170 (1977). https://doi.org/10.1007/BF01964915

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01964915

Keywords

Search

Navigation